This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Laboratorios Andromaco S.a., Universidad De La Frontera, Universidad Federal De Sao Paulo. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 7 
1 out of 14 
1 out of 2 
Years Active: 2015
Title: Inventor Andrés Rudolphy Fontaine – A Pioneer in Contraceptive Innovation
Introduction
Andrés Rudolphy Fontaine, based in Santiago, Chile, is an accomplished inventor known for his significant contributions to the field of contraceptive technology. With one patent to his name, Fontaine's work encapsulates his dedication to advancing reproductive health solutions.
Latest Patents
Fontaine's notable patent is directed toward an active agent with contraceptive properties, specifically a peptide fragment derived from venom. This innovative peptide generally includes the amino acid sequence of SEQ ID NO 2 or sequences that maintain at least 85% similarity. The invention encompasses both the peptide fragment and a pharmaceutical contraceptive composition, which combines the peptide with one or more pharmaceutically acceptable vehicles. These compositions prove valuable as contraceptive and spermicide agents, marking a significant advancement in contraceptive methods.
Career Highlights
Throughout his career, Fontaine has worked with prestigious institutions such as Universidad de La Frontera and Universidad de Chile. These affiliations have allowed him to collaborate with some of the brightest minds in the field, contributing to the body of knowledge surrounding reproductive health.
Collaborations
In his professional journey, Fontaine has collaborated closely with notable colleagues, including Fernando Gonzalo Romero Mejia and Raúl Sanchez Gutierrez. Their joint efforts have fostered innovation and research that underscore the importance of effective contraceptive solutions.
Conclusion
Andrés Rudolphy Fontaine stands out as a remarkable figure in the realm of contraceptive innovation. His patent represents a vital step forward in reproductive science, showcasing his commitment to enhancing and diversifying contraceptive methods. As the field continues to evolve, Fontaine's work serves as a testament to the impact that dedicated inventors can have on public health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile